Wani-gra

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Introduction

Hospitalised patients with SARS-CoV-2 infection often develop an intense hyperinflammatory state that can lead to multiple organ dysfunction, including acute respiratory distress syndrome, septic shock, and death.

1

  • Huang C
  • Wang Y
  • Li X
  • et al.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.